Celecoxib Crystallized from Hydrophilic Polymeric Solutions Showed Modified Crystalline Behavior with an Improved Dissolution Profile

Assay Drug Dev Technol. 2021 May-Jun;19(4):237-245. doi: 10.1089/adt.2020.1058. Epub 2021 May 7.

Abstract

The crystallization technique has been established as a cost-effective and simple approach to improve the dissolution rate and oral bioavailability of poorly soluble drugs. This study was carried out to study the effect of some selected hydrophilic polymers such as methyl cellulose, hydroxypropyl methylcellulose (HPMC), polyvinyl alcohol, and carboxymethyl cellulose on the crystal behavior and dissolution properties of celecoxib (CLX), a common nonsteroidal anti-inflammatory drug. Structural and spectral characteristics of crystallized CLX have been studied by Fourier transform infrared (FTIR) spectroscopy, diffraction scanning calorimetry (DSC), and X-ray diffraction (XRD) analysis. From FTIR and DSC analysis, no significant shifting of peaks or appearance of any new peaks (for polymers) were observed, which indicated the absence of any major interaction between drug and polymers as well as the absence of polymers in the final crystallized product of CLX. The XRD analysis showed a change in crystalline morphology to some extent. The dissolution rate of crystallized CLX in the presence of polymers (particularly with HPMC) was significantly improved compared with plain CLX. The improved dissolution profile of the experimental CLX crystal products could be an indication of improved bioavailability of CLX for better clinical outcome.

Keywords: celecoxib; crystal morphology; crystallization; dissolution study; hydrophilic polymer.

MeSH terms

  • Biological Availability
  • Calorimetry, Differential Scanning
  • Celecoxib / chemistry*
  • Crystallization
  • Crystallography, X-Ray
  • Cyclooxygenase 2 Inhibitors / chemistry*
  • Drug Carriers
  • Particle Size
  • Polymers / chemistry
  • Solubility
  • Solutions
  • Spectroscopy, Fourier Transform Infrared

Substances

  • Cyclooxygenase 2 Inhibitors
  • Drug Carriers
  • Polymers
  • Solutions
  • Celecoxib